Alison Armour
Corporate Officer/Principal presso Royal College of Physicians & Surgeons of Glasgow
Profilo
Attualmente, Alison A. Armour ricopre la posizione di vicepresidente senior per la ricerca e lo sviluppo presso Halozyme Therapeutics, Inc. La dottoressa Armour è anche membro del Royal College of Physicians & Surgeons di Glasgow. Il dottor Armour ha precedentemente ricoperto la posizione di vicepresidente di oncologia presso GlaxoSmithKline Plc, vicepresidente di oncologia presso Novartis AG e direttore medico di Endocyte, Inc. (una consociata di Novartis AG) e direttore della scienza medica globale di AstraZeneca Plc. Alison A. Armour ha conseguito una laurea, una laurea e un dottorato presso l'Università di Glasgow.
Posizioni attive di Alison Armour
Società | Posizione | Inizio |
---|---|---|
Royal College of Physicians & Surgeons of Glasgow
Royal College of Physicians & Surgeons of Glasgow Other Consumer ServicesConsumer Services The Royal College of Physicians and Surgeons of Glasgow is a multidisciplinary organization that sets standards of care for the prevention and treatment of sickness and trauma in travelers. The British company has published a good practice guide for providing a travel health service, which defines the standards of care every practitioner should achieve in their practice of travel medicine for the health and safety of the international traveler. The organization offers a wide range of membership benefits and discounts on clinical and non-clinical skills courses, conferences, and e-learning. The private company also provides examinations and assessments across medical, surgical, and dental specialties to advance the profession and improve patient care through continuing professional development. | Corporate Officer/Principal | - |
Precedenti posizioni note di Alison Armour
Società | Posizione | Fine |
---|---|---|
HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
NOVARTIS AG | Corporate Officer/Principal | 01/07/2015 |
GSK PLC | Corporate Officer/Principal | 01/07/2015 |
ASTRAZENECA PLC | Corporate Officer/Principal | 01/08/2011 |
ENDOCYTE, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Alison Armour
University of Glasgow | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
ASTRAZENECA PLC | Health Technology |
HALOZYME THERAPEUTICS, INC. | Health Technology |
NOVARTIS AG | Health Technology |
GSK PLC | Health Technology |
Aziende private | 2 |
---|---|
Endocyte, Inc.
Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Royal College of Physicians & Surgeons of Glasgow
Royal College of Physicians & Surgeons of Glasgow Other Consumer ServicesConsumer Services The Royal College of Physicians and Surgeons of Glasgow is a multidisciplinary organization that sets standards of care for the prevention and treatment of sickness and trauma in travelers. The British company has published a good practice guide for providing a travel health service, which defines the standards of care every practitioner should achieve in their practice of travel medicine for the health and safety of the international traveler. The organization offers a wide range of membership benefits and discounts on clinical and non-clinical skills courses, conferences, and e-learning. The private company also provides examinations and assessments across medical, surgical, and dental specialties to advance the profession and improve patient care through continuing professional development. | Consumer Services |